---

To Attend

For technical assistance please contact: Rakesh.Raghuwanshi@fda.hhs.gov

Speakers

Elizabeth Petro, PhD

Supervisory Chemist, Branch Chief

 

 

Megumi Yamamoto, MS
Chemist, Project Manager for Cosmetic Registration and Listing

 

Janet Zang, PhD

Supervisory Toxicologist, Branch Chief

Office of Cosmetics and Colors

Office of the Chief Scientist 

U.S. Food and Drug Administration
 

About the Speakers

Dr. Elizabeth Petro graduated with a bachelor’s degree in biological chemistry from the University of Chicago in 2006 and a doctorate in biological chemistry from the Johns Hopkins University School of Medicine in 2013.  Dr. Petro joined the FDA in 2014 reviewing food contact substance notifications in what was at that time the Office of Food Additive Safety in the FDA’s Center for Food Safety and Applied Nutrition (CFSAN).  Since January 2022, Dr. Petro has led the Cosmetics Regulatory Activities Branch, coordinating the FDA’s regulatory and compliance activities for cosmetic products.

Megumi Yamamoto is the project manager for Cosmetic Registration and Listing at the FDA, where she leads efforts related to the registration and listing of cosmetic product facilities and products under the Modernization of Cosmetics Regulation Act (MoCRA). Before joining the FDA in 2019, Yamamoto spent over 14 years in the cosmetics industry, specializing in formulation and product development for global brands such as Coty, Avon, and Estée Lauder. She holds a master’s degree in cosmetic science from Fairleigh Dickinson University and a bachelor’s degree in chemistry from the University of Connecticut.

Dr. Janet Zang is a supervisory toxicologist at the FDA who has served the agency since 2009. She currently holds the position of Chief of the Cosmetics Regulatory Science Branch in the Office of Cosmetics and Colors (OCAC), under the FDA's Office of Chief Scientist. In this capacity, Dr. Zang directs safety and risk assessment, research, and postmarket surveillance programs for cosmetic ingredients and products. Prior to her current role, Dr. Zang worked in CFSAN (now the Human Foods Program) for 11 years, during which she performed numerous toxicology and epidemiological reviews on chemical food contaminants as well as food additives, Generally Recognized as Safe (GRAS) substances, and color additives. With extensive experience in regulatory review, Dr. Zang has provided support to the agency's compliance actions, rulemaking, and other regulatory activities through rigorous scientific evaluation.

About the Presentation

This lecture will provide a comprehensive overview of the FDA's regulatory authorities over cosmetic products. Participants will also learn about the various tools available for industry to register their facilities and list their cosmetic products as required by MoCRA, and how industry and consumers can report adverse events from use of cosmetic products to the FDA.

Learning Objectives

1. Explain the FDA’s regulatory requirements for submitting adverse event reports for cosmetic products. 
2. Describe the available methods of reporting adverse event associated with the use of cosmetic products. 
3. Understand the key regulatory requirements for the registration and listing of cosmetic product facilities and products under the Modernization of Cosmetics Regulation Act (MoCRA), including who must comply, what information is required, and how to navigate the FDA’s registration and listing process.

Continuing Medical Education (CME) Credit

As CME credit is being offered through the Johns Hopkins University School of Medicine, those wishing to obtain CME credit must create a user profile on the Hopkins Cloud CME platform. If you have never had a CME certificate/credits awarded and need a user profile created, please log onto https://hopkinscme.cloud-cme.com and click the “Sign Up Now” button. DO NOT create a new account if you have already received credit for Johns Hopkins CME activities at any time. Click on Forgot Password if you already have an email on file with the JHU OCME office. Instructions on how to claim the CME credit will be provided during the Grand Rounds presentation, but participants must already have a Hopkins Cloud CME user profile before the presentation. 

Accreditation Statement

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Johns Hopkins University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This regularly scheduled series has been approved for a 52-week cycle beginning October 23, 2025.

Other Credits

Reciprocity exists with the following boards that accept AMA PRA Category 1 Credits™ from organizations accredited by the ACCME:

• American Nurses Credentialing Center (ANCC)
• American Academy of Nurse Practitioners National Certification Program (AANP)
• National Commission on Certification of Physicians Assistants (NCCPA)
• Psychologists: JHUSOM is authorized by the Maryland State Board of Examiners of Psychologists as a provider of continuing education. The JHUSOM maintains responsibility for this program.
• Social Workers: The Maryland Board of Social Work Examiners certifies that this program meets the criteria for 1 credit hour of Category 1 of continuing education for social workers licensed in Maryland. The JHUSOM is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.

These professionals should submit their transcript to their respective boards to convert their credits to CEUs.

Policy on Presenter and Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the presenter globally disclose conflicts of interest and any discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.